Bioanalysis

Article	Citations
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO	35
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population	29
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox	28
Adopting ambient ionization mass spectrometry into bioanalytical laboratories	26
Degradation of Vancomycin in External Quality Assessment Samples is a Factor to Underestimate Its Concentration	25
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid	23
Simple Method to Determine the Concentration and Incorporation Ratio of Ruthenium-Labeled Antibodies	23
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery	23
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar	20
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis	19
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy	19
High-Sensitivity Workflow for LC–MS-Based Analysis of GALNAC-Conjugated Oligonucleotides: A Case Study	18
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testing	15
Patient-centric clinical trials: collaboration and innovation in bioanalytical and clinical operations	14
Whole blood stability in bioanalytical method validation: updated recommendations from the European Bioanalysis Forum	14
Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients	13
Validation of Enantioseparation and Quantitation of an Active Metabolite of Abrocitinib in Human Plasma	13
Determination of IQZ23 in Rat Plasma using LC-MS/MS: Consideration for Matrix Effect and Internal Standard Interference	13
Handling Unstable Analytes: Literature Review and Expert Panel Survey by the Japan Bioanalysis Forum Discussion Group	13
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses	12
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics	12
The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS	11
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA	11
Simultaneous Measurement of Mouse and Human Albumin in Chimeric Mice with Humanized Livers	11
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Anahita Keyhani	11

Comparison of Assay Formats Used for the Detection of Pre-Existing Anti-Drug Antibodies Against Monoclonal Antibodies	11
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique	11
Special Focus Issue - Covid-19: Bioanalytical Considerations, Contributions and Lessons – Part 2	10
A novel LC-MS/MS method for simultaneous estimation of chlordiazepoxide and clidinium in human plasma and its application to pharmacokinetic assessment	10
Bioanalysis Rising Star Award 2024: interviews with the finalists	10
Perspectives on a Flexible Strategy for the Management of Nonregulated Bioanalysis	9
An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma	9
Ligand-binding assays vs chromatographic platforms for oligonucleotide quantification	9
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency	9
Validation of an LC–MS/MS method for the determination of sotorasib, a KRAS G12C inhibitor, in human plasma	9
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers	9
Inception and Development of a LC–MS/MS Assay for the Multiplexed Quantitation of Nine Human Drug Transporter Biomarkers	8
Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System	8
Olympic Anti-Doping Laboratory: The Analytical Technological Road From 2016 Rio De Janeiro to 2021 Tokyo	8
Western Blotting: Evolution of an Old Analytical Method To a New Quantitative Tool for Biomarker Measurements	8
Determination of meropenem in capillary plasma microsamples using LC–MS/MS	8
Method development for the quantification of lead levels in whole blood sampled on Mitra ® with VAMS ® tips by inductively coupled	8
Highlights of the 13th Japan Bioanalysis Forum Symposium	8
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS	8
Highlights of the 15th Japan Bioanalysis Forum Symposium	8
Novel Isoelectric Target Depletion (ITaD) Protocol Reduces the Need for Specific Reagents for Immunogenicity Testing	7
High Ionic Strength Dissociation Assay Reduces Dimeric Target Interference in Immunogenicity Testing	7
Molecularly Imprinted Electrochemical Biosensor for Thrombin Detection by Comparing Different Monomers	7
Special Focus Issue - Performing Flow Cytometry in Clinical Trials	7
Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics	7
Development and Validation of qPCR Methods for Nucleic Acid Biomarkers as a Drug Development Tool: Points to Consider	7
A Sensitive, Robust and High-Throughput Isotope Dilution LC–MS/MS Method for Quantifying Three Folate Forms in Serum	7
Critical Reagent Inventory Management System and Web Portal Specifically Optimized for Supporting External Clients	7
DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma	7
Validation of UV–Vis spectrophotometric colorimetric methods for Rifampicin quantification in PBS & biological matrices	7
Upfront Acid Treatment with Low Final pH: The Development and Testing of a Novel Method to Improve Drug Tolerance in Antidrug Antibody Assays	7
Determination of Amphetamines, Opioids, Cocaine Metabolites and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Using Biocompatible Solid-Phase Microextraction and Ultra-Performance LC–MS/MS	7
Development of an LC-MS/MS assay to analyze a lipid-conjugated siRNA by solid phase extraction (SPE) in mouse plasma and tissue using a stable isotope labeled internal standard (SILIS)	7
Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations	7
An Eco-Friendly Ultra-Performance Liquid Chromatography–Mass Spectrometry Method for Quantification of Rivaroxaban and Ticagrelor in Rat Plasma: Grapefruit Interactions	7
Determination of aloesone in rat plasma by LC–MS/MS spectrometry and its application in a pharmacokinetic study	6
Quantitation of BCAA and BCKA in plasma and patient-centric dried blood microsamples in a clinical setting	6
HPLC Method for Simultaneous Estimation of Paclitaxel and Baicalein: Pharmaceutical and Pharmacokinetic Applications	6
Comparison of Requirements for Clinical Study of SARS-CoV-2 Antigen Test Kits in China, the USA and Europe	6
Development and validation of bioanalytical methods to support clinical study of disitamab vedotin	6
Perspective on High-Throughput Bioanalysis to Support In Vitro Assays in Early Drug Discovery	6
Revolutionizing depression diagnosis: earwax analysis for cortisol and beyond	6
Cytochrome P450 Enzymes: A Review on Drug Metabolizing Enzyme Inhibition Studies in Drug Discovery and Development	6
Ocular Bioanalysis of Moxifloxacin and Ketorolac Tromethamine in Rabbit Lacrimal Matrix Using Liquid Chromatography–Tandem Mass Spectrometry	6
Greener Bioanalytical Sample Preparation. What is Next?	6
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform	5
Effect of Chronopharmacology and Food on in Vivo Pharmacokinetic Profile of Mavacamten	5
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma	5
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS	5
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study	5

Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV	5
Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis	5
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats	5
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling	5
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates	5
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum	5
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis	5
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development	5
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications	5
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens	5
Detection of Streptococcus anginosus in fecal samples using PCR-CRISPR /Cas12a system	5
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies	4
Harmonization of Vaccine Ligand Binding Assays Validation	4
Bioanalytical tandem mass spectrometry method for cinacalcet in human plasma: green assessment with advanced metrics	4
Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective	4
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control	4
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management	4
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid	4
Thyroxine Biosensors: A Review on Progress and Challenges	4
Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment	4
Cloud Solutions for GxP Laboratories: Considerations for Data Storage	4
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine	4
Assessing linearity of vaccine immunogenicity assays: application and link with clinical endpoints	4
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents	4
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy	4
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective	4
Insights and Future Trends in Bioanalysis: An Interview With Jing Tu	4
Utilizing Droplet Digital Polymerase Chain Reaction for siRNA Quantitation in Rodent Plasma and Tissue Via Stem-Loop Reverse Transcription	4
Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel	4
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development	4
Development and validation of highly sensitive ligand binding assay to measure soluble DLL3 concentration in human serum	4
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats	4
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis	4
LC-MS/MS method for co-estimation of doxorubicin and piperine: formulation development and pharmacokinetic studies	4
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis	4
High-resolution mass spectrometry for glycoproteomics	4
Validated HPLC Method for Ceftriaxone from Dried Blood Spots for Pharmacokinetic Studies and Therapeutic Drug Monitoring in Neonatal Population	4
Capillary Electrophoresis Mass Spectrometry for Metabolomics: Reflecting on the Next Steps	4
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides	4
Accelerating isotope dilution LC-MS-based desmosine quantification for estimating elastin turnover	3
Research progress of N -nitrosamine detection methods: a review	3
Green HPLC method for determination of paracetamol and ibuprofen in human plasma: applications to pharmacokinetics	3
A Bioanalytical Screening Method for Enterococcus faecalis RNPP-type Quorum Sensing Peptides in Murine Feces	3
Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study	3
Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories	3
Technique Development of High-Throughput and High-Sensitivity Sample Preparation and Separation for Proteomics	3
With Great Power Comes Great Responsibility: High-Dimensional Spectral Flow Cytometry to Support Clinical Trials	3
Welcome to Volume 14 of Bioanalysis	3
Large Molecule Bioanalysis by LC–MS: Beyond Simply Quantifying	3
Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables	3
Advances in green sample preparation methods for bioanalytical laboratories focusing on drug analysis	3
Comparison of Liquid–Liquid Extraction, Microextraction and Ultrafiltration for Measuring Free Concentrations of Testosterone and Phenytoin	3
Integrating metering capabilities to increase the utility of self-collected, dried samples	3
Testing in the Workplace: Finding a Path Through a Pandemic	3
China's NMPA Perspective on the Clinical Performance of SARS-CoV-2 Antigen Test Reagents	3
Singlicate analysis in ADA assays: comparing assay performance in duplicate and singlicate formats	3
Simultaneous estimation of donepezil and quercetin using ultra high performance liquid chromatography: pharmaceutical and pharmacokinetic applications in Alzheimer’s disease	3
Nitrosamine Impurities: from Raw Materials to Final Drug Product	3
Bioanalysis Rising Star Award 2023: announcing our finalists	3
A Validated Capillary Microsampling Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Antisense Oligonucleotides in Mouse Serum	3
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bio	3
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective	3
LC–MS/MS Bioanalytical Method for Quantification of Binimetinib and Venetoclax, and their Pharmacokinetic Interaction	3
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?	3
High-Throughput MS for Intact Protein Analysis	3
Volumetric absorptive microsampling–LC–MS/MS assays for quantitation of giredestrant in dried human whole blood	3
Quantifying skin permeation of a novel metformin lotion using modified hydrophilic interaction liquid chromatography	3
Simultaneous quantitation of tigecycline, meropenem, polymyxin B in plasma, and protein-binding analysis in HSCT patients	3
Enantioselective electrochemical detection of a L-and D-serine at polyvinylpyrrolidone-modified platinum electrode	3
LC-MS/MS Methods to quantify HCP002 in Human Plasma and Urine: Applications in a Pharmacokinetic Study	3
Multi-residue analysis method based on QuEChERS followed by ultra-high performance liquid chromatography coupled with diode-array detector for pesticides in human serum and breast milk	3
Feasibility of using PALSAR technology as a signal amplifier for antibody bridging assay	3
Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS	3
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum	3
Artificial intelligence and blockchain in clinical trials: enhancing data governance efficiency, integrity, and transparency	3
Pharmacokinetics and Toxicity Considerations for Antibody–drug Conjugates: An Overview	3
Blood Cell Quantification on Dry Blood Samples: Toward Patient-Centric Complete Blood Counts	3
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies	3
High-sensitivity Quantification of Antisense Oligonucleotides for Pharmacokinetic Characterization	3
Thalidomide Measurement in Plasma and Dried Plasma Spot by SPE Combined with UHPLC-MS/MS for Therapeutic Drug Monitoring	3

Analytical Considerations to Support Expeditious Formulation Development of Vaccines	3
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments;	3
Development and Validation of Reversed-Phase-HPLC Method for Simultaneous Quantification of Fulvestrant and Disulfiram in Liposomes	3
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis	3
Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum	3
Two decades of immunocapture liquid chromatography tandem mass spectrometry for pharmaceutical discovery and development: reflections and recommendations for optimal deployment	2
A Simple Isotope-Labeled UHPLC–MS/MS Assay for Simultaneous Quantification of Methotrexate, Imatinib and Dasatinib	2
HPLC–MS/MS Studies of Brimonidine in Rabbit Aqueous Humor By Microdialysis	2
Considerations for Drug Development Biomarker Assays in the Clinical Laboratory	2
Sensitive LC-MS/MS Quantification of Unconjugated Maytansinoid DM4 and its Metabolite S-methyl-DM4 in Human Plasma	2
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-tocilizumab antibodies	2
Pharmacokinetic study of isavuconazonium in human plasma measured by HPLC-MS/MS and its use in healthy Chinese subjects	2
16 th GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytica	2
Observations from a decade of oligonucleotide bioanalysis by LC-MS	2
An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma	2
Evaluation of the light-initiated chemiluminescence assay for quantification of Humulus scandens pollen - specific IgE	2
Can capillary microsampling facilitate a clinical pharmacokinetics study of cefazolin in critically ill children?	2
Analysis of Free Concentrations of Lamotrigine and Active Oxcarbazepine Metabolite in Clinical Patients by Hollow-Fiber Centrifugal Ultrafiltration	2
Development and Validation of an LC-MS/MS Method for Determination of a Novel Anticancer Agent (CPI-613) in HumanPlasma	2
Simultaneous Estimation of Raloxifene and Cladrin by HPLC: Application to Metabolic Stability Studies in Different Species	2
Latest developments in the detection and quantification of adrenaline: advances and clinical applications	2
A High-Speed Microscopy System Based on Deep Learning to Detect Yeast-Like Fungi Cells in Blood	2
Validated GC-MS methods to detect ethylene, diethylene, and triethylene glycol in serum, plasma, and urine samples	2
Effect of delayed blood centrifugation on cytokine quantitation in serum and plasma	2
Green Bioanalysis: An Innovative and Eco-Friendly Approach for Analyzing Drugs in Biological Matrices	2
Unique challenges required reassessment and alterations to critical reagents to rescue a neutralizing antibody assay	2
Analytical Techniques for Monitoring of Toluene and Xylene Exposure Biomarkers Hippuric Acid and Methylhippuric Acid in Human Urine Samples	2
Meet the Editorial Board: An Introduction to and Insights from Fumin Li	2
Preclinical Pharmacokinetics of 4-Hydroxy Isoleucine Using Lc–Ms/Ms: A Potential Polycystic Ovary Syndrome Phytopharmaceutical Therapeutics	2
Highlights of the 12Th Japan Bioanalysis Forum Symposium	2
Tuberculosis diagnosis versus GeneXpert ® MTB/RIF formats	2
Comparison of Pharmacokinetic Profiles in Hypoalbuminemia and Healthy Rats After Parecoxib Sodium Injection by LC–MS/MS	2
A rapid and sensitive UHPLC-MS/MS method for epalrestat detection in micro-volumes of human plasma for the first time	2
The use of surrogate matrices in bioanalytical preclinical safety testing using chromatographic methods: a recommendation from the European Bioanalysis forum	2
The Biomarker Bandwagon's Quantitative Quandary: 10 years of Tuning	2
Evaluation of singlicate vs duplicate analysis in ligand binding assays: a case study with IFN-γ in mouse and NHP models	2
Determination of drugs of abuse and metabolites in plasma microsamples by LC-MS/MS after microQuEChERS extraction	2
A Competitive Ligand-Binding Assay to Detect Neutralizing Antibodies to a Bispecific Drug Using a Multiplex Meso Scale Discovery Platform	2
Immunoassay Automation is Driving Advancements in Cell and Gene Therapies	2
Using Innovative Tools for In Vitro Absorption, Distribution, Metabolism and Excretion Studies to Efficiently and Effectively Support Drug Development	2
Surrogate Peptide Selection and Internal Standardization for Accurate Quantification of Endogenous Proteins	2
WRIB Poster Awards Winners 2024	2
Navigating IVDR challenges for pharmacokinetic, anti-drug antibodies, and biomarker assays in early clinical research: a recommendation from the European Bioanalysis Forum	2
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline	2
Development and validation of an LC–MS/MS method to quantify kynurenic acid in human plasma	2
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena	2
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?	2
Bioanalysis of INCB000928 in hemodialysate: prevention of nonspecific binding and validation of surrogate matrices	2
Approaches to Overcome the Challenge of Sample Stability for Flow Cytometry Analysis in Clinical Trials	2
The GSK Bioanalytical Hub Model in Bioanalysis: Maximizing the Synergies of Co-Locating Various Platforms in Support of Regulated and Nonregulated Study end Points	2
Effective Biomarker Measurement is Key for Biotherapeutic Development	2
Determination of Levetiracetam by GC-MS and Effects of Storage Conditions and Gastric Digestive Systems on Drug Samples	2
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Shefali R Patel	2
Highlights of the 14th Japan Bioanalysis Forum Symposium	2
Stability of Nonsteroidal Anti-Inflammatory Drugs in Urine and Solution: Effects of Degradation on Analytical Assessment	2
A Flow Cytometric Journey Into Cell Cycle Analysis	2
Feedback from the 10th European Bioanalysis Forum Young Scientist Symposium and from the Science Café discussions on sustainability in bioanalysis	2
Development of a UPLC–MS/MS Method for Determination of a Dual EZH1/2 Inhibitor UNC1999 in Rat Plasma	2
Conference report for the 10th China Bioanalysis Forum annual meeting	2
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device	2
Impact of positive control binding properties on anti-drug antibody assay performance	2
Pharmacokinetic analysis using single dilution assays: enhancing precision, reducing errors and increasing throughput	2
Recommendations on qPCR/ddPCR Assay Validation by GCC	2
Quantitative Chromatographic Method Development for Residual Lidocaine in Topical Systems and Biological Samples	2
Bioanalysis of Six Antibiotics from Volumetric Microsamples: A New Tool for Precision Dosing in Critically ill Children	2
Immunocapture LC–MS Methods for Pharmacokinetics of Large Molecule Drugs	2
Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study	2
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolonga	2
Evaluation of hemaPEN ® sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS/MS	2
An insight into the presence of impurities in reference standards and their impact on mass spectrometry-based bioanalysis	1
A green bioanalytical spectrofluorimetric approach for estimation of Avapritinib anti-tumor drug; application to quality control and clinical studies	1
Bioanalytical method validation and sample analysis for nirmatrelvir in dried blood collected using the Tasso-M20 device	1
Running the Assay of 2023 and Introducing Bioanalysis volume 16	1
Bioanalysis of antihypertensive drugs by LC-MS: a fleeting look at the regulatory guidelines and artificial intelligence	1
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vacc	1
Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis	1
Regen-Cov ® Antibody Cocktail Bioanalytical Strategy: Comparison of Lc-Mrm-Ms and Immunoassay Methods for Drug Quantification	1
A Sensitive LC–MS/MS Assay to Quantitate Free Payload Aur0101 from ADC PYX-201 in Rat and Monkey Plasma	1
Development of Fe 3 O 4 /Reduced Graphene Oxide Nanocomposite-Based Dispersive Solid-Phase Extraction for the Quantification of Fi	1
Why traditional validation may fall short for artificial intelligence in bioanalysis: a perspective from the European Bioanalysis Forum	1
Assessing prognosis by quantifying FcγRIIa on fixed platelets	1
Understanding quantitative polymerase chain reaction bioanalysis issues before validation planning: Japan Bioanalysis Forum discussion group	1
Quantitation of anacetrapib in human and animal adipose by liquid chromatography with mass spectrometric detection	1
A Singlicate Immunogenicity Method to Detect Anti-Polyethylene Glycol Antibodies: Pre- and Post-Dose of PEGylated Therapies	1
Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry	1
Risk-Based Approach of Bioanalytical Methods for Clinical Immunogenicity Assessment of Multidomain Biotherapeutics	1
Novel Sequential Immunocapture Microflow LC/MS/MS Approach to Measuring PTH-Fc Protein in Human Serum	1
Practical Aspect of Dimer Adduct Formation in Small-Molecule Drug Analysis with Lc-Ms/Ms	1
Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins	1
Development and validation of carbodiimide-activated ELISA plate for quantifying IgG levels against Streptococcus pneumoniae capsular polysaccharides	1
Feedback From the Science Café At the 7Th European Bioanalysis Forum Young Scientist Symposium	1
Determination of drugs of abuse in oral fluid using dried oral fluid spot assisted by 24-well plate and LC–MS/MS	1
Development, Validation and Application of an Ion-Pair Reversed-Phase Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Nusinersen	1
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability &	1
Overcoming Challenges Associated with the Bioanalysis of Cysteine-Conjugated Metabolites in the Presence of Antibody–Drug Conjugates	1